| Financial Year |
March 31 2023 |
| Monetary Funds |
256,669,503.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,902,993.77 |
| Accounts Receivable |
1,750,447,501.46 |
| Advances to Suppliers |
133,868,259.75 |
| Other Receivables |
138,499,092.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
42,602,748.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
39,501,019.16 |
| Other Current Assets |
1,907,296.51 |
| Total Current Assets |
4,412,488,998.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
559,440,604.81 |
| Investment Properties |
557,349,609.88 |
| Fixed Assetes |
209,805,719.93 |
| Under-construction Projects |
155,083,748.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
212,829,859.81 |
| R&D expenses |
38,420,526.22 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
803,897.70 |
| Deferred Income Tax Assets |
77,634,240.28 |
| Other Non-Current Assets |
187,693,801.50 |
| Sub-Total of Non-Current Assets |
2,117,576,627.02 |
| Total Assets |
6,530,065,625.33 |
| Short-Term Loans |
1,490,356,333.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
100,348,451.82 |
| Accounts Payable |
874,516,538.37 |
| Accounts Received In Advance |
10,963,746.90 |
| Employee Compensation Payable |
11,922,525.80 |
| Taxes Payable |
87,710,093.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
78,235,157.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,797,470.72 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,684,227,412.13 |
| Long-term Loans |
375,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
27,696,844.30 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,829,964.32 |
| Other Non-Current Liabilities |
214,617,300.00 |
| Sub-Total of Non-Current Liabilities |
261,516,918.62 |
| Total Liabilities |
2,945,744,330.75 |
| Paid-In Capital(Or Share Stock) |
655,789,086.00 |
| Capital Surplus |
1,549,737,490.53 |
| Surplus Reserve |
178,335,922.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,187,605,291.04 |
| Minority Stockholder's Interest |
27,855,544.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,556,465,750.47 |
| Owner's Equity（Stockholder's Equity） |
3,584,321,294.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,530,065,625.33 |
